利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

8 条记录 (耗时 0.009 秒)

    THERAPEUTIC CREAM FOR DERMATITIS
    2.
    发明公开
    THERAPEUTIC CREAM FOR DERMATITIS 有权
    治疗创伤发作

    公开(公告)号：EP1495763A1

    公开(公告)日：2005-01-12

    申请号：EP02718592.5

    申请日：2002-04-15

    申请人： Santo, Tetsuo

    发明人： SANTO, Tetsuo ,  LI, Songhua ,  WANG, Ruwei ,  IWASAKI, Sumio

    IPC分类号： A61K35/78 ,  A61K31/10 ,  A61K31/16 ,  A61K7/00 ,  A61K7/48 ,  A61P17/00 ,  A61P7/00

    CPC分类号： A61Q19/00 ,  A61K8/97 ,  A61K31/10 ,  A61K31/16 ,  A61K31/60 ,  A61K36/185 ,  A61K36/232 ,  A61K36/234 ,  A61K36/315 ,  A61K36/484 ,  A61K36/489 ,  A61K36/539 ,  A61K36/575 ,  A61K36/65 ,  A61K36/704 ,  A61K36/752 ,  A61K36/756 ,  A61K36/9066 ,  A61K2300/00

    摘要： TECHNICAL FIELD: Cream for therapy of dermatitis TECHNICAL PROBLEM: To provide a cream for therapy effective against atopic dermatitis.
    MEANS FOR SOLVING: It has a composition: Lightyellow Sophora Root, 3%; Turmeric, 2%; Magnolia Bark, 2%; Moutan Bark, 2%; Isatis
    Leaf, 1%; Borneo Camphor Tree (Dryobalanops aromatica Gaertn. f.), 1%; Baikal Skullcap, 2%; Amur Cork Tree, 2%; Angelicae Dahuricae Root, 1%; Lemon, 3%; Smartweed, 2%; Licorice, 0.5%; Cnidii Rhizoma, 0.5%; Japanese Angelica Root, 0.5%; salicylic acid, 0.5%; resorcinol, 0.5%; mutton oil, 3%; alcohol, 3%; and white soft paraffin, 70.5%.
    An innovative therapy of various dermatitis such as atopic dermatitis can be attained by antibacterial, antiviral, antiallergic, antiphlogistic, blood-circulation accelerating, antifungal, sterilizing, anti-itching actions by the above respective ingredients, accelerating action for permeation of pharmacologically active ingredients to deep region of skin by Cnidii Rhizoma and Japanese Angelicae Root, accelerating action for keratinization in the diseased part by salicylic acid and resorcinol.
    Principal Use: It is used for the therapy of dermatitis, particularly of atopic dermatitis.

    摘要翻译： 技术领域：用于治疗皮炎的霜技术问题：为治疗特应性皮炎提供治疗霜。 解决方法：它有一个组成：Lightyellow Sophora Root，3％; 姜黄，2％; 木兰树皮2％; 木桐树皮2％; 叶子，1％; 婆罗洲樟树（Dryobalanops aromatica Gaertn。f。），1％; Baikal Skullcap，2％; 阿穆尔软木树，2％; 当归Dahuricae根，1％; 柠檬，3％ Smartweed，2％; 甘草，0.5％; Cnidii Rhizoma，0.5％; 日本当归根，0.5％; 水杨酸，0.5％; 间苯二酚，0.5％; 羊油3％; 酒，3％; 和白色软石蜡，70.5％。 各种皮炎如创伤性皮炎的创新疗法可以通过抗菌，抗病毒，抗过敏，消炎，血液循环加速，抗真菌，灭菌，上述各成分的抗瘙痒作用，加速渗透作用 药理活性成分由Cnidii Rhizoma和日本当归根深入皮肤区域，通过水杨酸和间苯二酚加速患病部位的角质化作用。 主要用途：用于治疗皮炎，特别是特应性皮炎。

    THERAPEUTIC LOTION FOR DERMATITIS
    3.
    发明授权
    THERAPEUTIC LOTION FOR DERMATITIS 有权
    治疗性LOTION反对皮炎

    公开(公告)号：EP1495762B1

    公开(公告)日：2009-11-11

    申请号：EP02717158.6

    申请日：2002-04-15

    申请人： Santo, Tetsuo

    发明人： SANTO, Tetsuo ,  LI, Songhua ,  WANG, Ruwei ,  IWASAKI, Sumio

    IPC分类号： A61P17/00 ,  A61K36/00 ,  A61K9/08

    CPC分类号： A61K36/575 ,  A61K31/10 ,  A61K31/16 ,  A61K36/185 ,  A61K36/315 ,  A61K36/48 ,  A61K36/65 ,  A61K36/9066 ,  A61K2300/00

    摘要： Technical Field: A therapeutic lotion for dermatitis. Technical Problems: To provide a therapeutic lotion efficacious for atopic dermatitis. Means for Resolution: Having a composition of 3% of Sophora radix, 2% of Curcuma aromatisca, 2% of Magnoliae cortex, 2% of Montan cortex, 1% of Baphicacanthes cusia, 1% of Borneolum syntheticum, 2% of Phellodendri cortex, 1% of Angellica dahurica, 3% of lemon, 2% of Polygonum cuspidatum, 0.5% of Glycyrrhizae radix, 0.5% of Chidii rhizoma, 0.5% of Angelica acutiloba, 0.5% of salicylic acid, 0.5% of resorcin, 30% of alcohol and 48.5% of water. Owing to synergistic action of the antibacterial, antiviral, antiallergic, antiinflammtory and blood circulation-accelerating effects of the above-described of Sophora radix, Curcuma aromatisca, Magnoliae cortex, Montan cortex, Baphicacanthes cusia, Borneolum syntheticum, Phellodendri cortex, Angellica dahurica, lemon, Polygonum cuspidatum and Glycyrrhizae radix, the skin-penetration accelerating, antifungal and sterrilizing effects of Chidii rhizoma and Angelica acutiloba, and the cornificaiton-accelerating, antifungal and sterilizing effects of salicylic acid and resorcin, a remarkable therapeutic effect can be established on atopic dermatitis. Major use: To be used in treating dermatitis, in particular, atopic dermatitis.

    THERAPEUTIC LOTION FOR DERMATITIS
    4.
    发明公开
    THERAPEUTIC LOTION FOR DERMATITIS 有权
    治疗性LOTION反对皮炎

    公开(公告)号：EP1495762A4

    公开(公告)日：2006-04-12

    申请号：EP02717158

    申请日：2002-04-15

    申请人： SANTO TETSUO

    发明人： SANTO TETSUO ,  LI SONGHUA ,  WANG RUWEI ,  IWASAKI SUMIO

    IPC分类号： A61P17/00 ,  A61K8/97 ,  A61K31/10 ,  A61K31/16 ,  A61K31/60 ,  A61K36/185 ,  A61K36/315 ,  A61K36/48 ,  A61K36/575 ,  A61K36/65 ,  A61K36/9066 ,  A61K45/08 ,  A61P7/00 ,  A61Q19/00

    CPC分类号： A61K36/575 ,  A61K31/10 ,  A61K31/16 ,  A61K36/185 ,  A61K36/315 ,  A61K36/48 ,  A61K36/65 ,  A61K36/9066 ,  A61K2300/00

    摘要： TECHNICAL FIELD: Lotion for therapy of dermatitis TECHNICAL PROBLEM: To provide a lotion for therapy effective against atopic dermatitis. MEANS FOR SOLVING: It has a composition: Lightyellow Sophora Root, 3%; Turmeric, 2%; Magnolia Bark, 2%; Moutan Bark, 2%; Isatis Leaf, 1%; Borneo Camphor Tree (Dryobalanops aromatica Gaertn.f.), 1%; Amur Cork Tree, 2%; Angelicae Dahuricae Root, 1%; Lemon, 3%; Smartweed, 2%; Licorice, 0.5%; Cnidii Rhizoma, 0.5%; Japanese Angelica Root, 0.5%; salicylic acid, 0.5%; resorcinol, 0.5%; alcohol, 30%; and water, 48.5%. A significant therapeutic effect against atopic dermatitis is obtained by a synergistic effect between antibacterial, antiviral, antiallergic, antiphlogistic, and blood-circulation accelerating actions as pharmacological effects of Lightyellow Sophora Root, Turmeric, Magnolia Bark, Moutan Bark, Isatis Leaf, Borneo Camphor Tree (Dryobalanops aromatica Gaertn.f.), Amur Cork Tree, Angelicae Dahurikae Root, Lemon, Smartweed, and Licorice, accelerating action for skin permeation and antifungal-sterilizing action of Cnidii Rhizoma and Japanese Angelicae Root, accelerating action for keratinization and antifungal-sterilizing action of salicylic acid and resorcinol, as described above. Principal Use: It is used for the therapy of dermatitis, particularly of atopic dermatitis.

    DRINKING TEA FOR TREATING DERMATITIS
    5.
    发明公开
    DRINKING TEA FOR TREATING DERMATITIS 审中-公开
    TEEGETRÄNKZUR BEHANDLUNG VON DERMATITIS

    公开(公告)号：EP1495764A1

    公开(公告)日：2005-01-12

    申请号：EP02718594.1

    申请日：2002-04-15

    申请人： Santo, Tetsuo

    发明人： SANTO, Tetsuo ,  LI, Songhua ,  WANG, Ruwei ,  IWASAKI, Sumio

    IPC分类号： A61K35/78 ,  A61K9/08 ,  A61P17/00 ,  A23L1/38

    CPC分类号： A61K36/704 ,  A23F3/34 ,  A23L33/105 ,  A23V2002/00 ,  A61K36/185 ,  A61K36/232 ,  A61K36/287 ,  A61K36/30 ,  A61K36/315 ,  A61K36/484 ,  A61K36/489 ,  A61K36/505 ,  A61K36/534 ,  A61K36/539 ,  A61K36/748 ,  A61K36/752 ,  A61K36/90 ,  A61K2300/00 ,  A23V2250/214 ,  A23V2250/21

    摘要： TECHNICAL FIELD: Tea
    TECHNICAL PROBLEM: To provide a drinkable tea having a high therapeutic effect against atopic dermatitis.
    MEANS FOR SOLVING: It is characterized in that it contains extracts drawn from one, two or more medicinal herbs selected from the group consisting of Lightyellow Sophora Root, Isatis Leaf, and Terminalia Fruit. Atopic dermatitis can be cured by improving allergic constitution from the inside of body owing to antibacterial effect and antiviral effect of Lightyellow Sophora Root, Isatis Leaf and Terminalia Fruit, antiallergic effect of Lightyellow Sophora Root and Isatis Leaf, and intestinal mucosal protecting effect of Terminalia Fruit, or by a synergistic effect of them.
    In addition, the pharmacological effect in said extracts drawn from plants is enhanced, a pharmacological effects lacking in said extracts drawn from plants are added, or easiness of drinking the tea as a drinkable drug is improved and thus the therapeutic effect is improved by adding one, two or more auxiliary materials selected from the group of Japanese Angelica Root, Oldenlandia diffusa, Smilax Glabra, Dried Tangerine Peel, Wild Chrysanthemum Flower, Corydalis, Peppermint, Baikal Skullcap, Lithospermum, Kudingcha, Smartweed, and Licorice to the extracts drawn from plants.
    Principal Use: It is used for the therapy of dermatitis, particularly of atopic dermatitis.

    摘要翻译： 技术领域：茶技术问题：提供对特应性皮炎具有高治疗作用的饮用茶。 解决方法：其特征在于，其含有从一种，两种或更多种选自由淡黄色苦参，Is叶和终末果实组成的组中提取的提取物。 特应性皮炎可以通过改善身体内部的过敏性体质而得到治愈，这是由于Lightyellow Sophora Root，Isatis Leaf and Terminalia Fruit的抗菌作用和抗病毒作用，Lightyellow Sophora Root和Isatis Leaf的抗过敏作用，以及Terminalia Fruit的肠粘膜保护作用 ，或通过它们的协同效应。 此外，从植物提取的所述提取物中的药理作用增强，从植物中提取的所述提取物中缺乏药理作用，或者作为可饮用药物饮用茶的容易性提高，因此治疗效果为 通过添加选自日本当归根，奥兰德兰德兰，Sm ra，干桔皮，野菊花，延胡索，薄荷，贝加尔骷髅，紫草，葛根，仙妮草，甘草中的一种，两种或更多种辅助材料， 从植物提取的提取物。 主要用途：用于治疗皮炎，特别是特应性皮炎。

    THERAPEUTIC CREAM FOR DERMATITIS
    6.
    发明授权
    THERAPEUTIC CREAM FOR DERMATITIS 有权
    治疗性CREAM皮炎

    公开(公告)号：EP1495763B1

    公开(公告)日：2009-03-18

    申请号：EP02718592.5

    申请日：2002-04-15

    申请人： Santo, Tetsuo

    发明人： SANTO, Tetsuo ,  LI, Songhua ,  WANG, Ruwei ,  IWASAKI, Sumio

    IPC分类号： A61K36/00 ,  A61K31/10 ,  A61K31/16 ,  A61P17/00

    CPC分类号： A61Q19/00 ,  A61K8/97 ,  A61K31/10 ,  A61K31/16 ,  A61K31/60 ,  A61K36/185 ,  A61K36/232 ,  A61K36/234 ,  A61K36/315 ,  A61K36/484 ,  A61K36/489 ,  A61K36/539 ,  A61K36/575 ,  A61K36/65 ,  A61K36/704 ,  A61K36/752 ,  A61K36/756 ,  A61K36/9066 ,  A61K2300/00

    摘要： Technical Field: A therapeutic cream for dermatitis. Technical Problems: To provide a therapeutic cream efficacious for atopic dermatitis. Means for Resolution: Having a composition of 3% of Sophora radix, 2% of Curcuma aromatisca, 2% of Magnoliae cortex, 2% of Montan cortex, 1% of Baphicacanthes cusia, 1% of Borneolum syntheticum, 2% of Scutellariae radix, 2% of Phellodendri cortex, 1% of Angellica dahurica, 3% of lemon, 2% of Polygonum cuspidatum, 0.5% of Glycyrrhizae radix, 0.5% of Chidii rhizoma, 0.5% of Angelica acutiloba, 0.5% of salicylic acid, 0.5% of resorcin, 3% of lanoline, 3% of alcohol and 70.5% of white petrolactum. Owing to synergistic action of the antibacterial, antiviral, antiallergic, antiinflammtory, blood circulation-accelerating, antifungal, sterilizing and antipruritic effects of the above-described components, the effect of accelerating the penetration of active ingredients into the deep part under the skin of Chidii rhizoma and Angelica acutiloba, and the cornificaiton-accelerating effects of salicylic acid and resorcin, various dermatites such as atopic dermatitis can be innovatively treated. Major use: To be used in treating dermatitis, in particular, atopic dermatitis.

    THERAPEUTIC LOTION FOR DERMATITIS
    8.
    发明公开
    THERAPEUTIC LOTION FOR DERMATITIS 有权
    治疗脂肪酸摄入量

    公开(公告)号：EP1495762A1

    公开(公告)日：2005-01-12

    申请号：EP02717158.6

    申请日：2002-04-15

    申请人： Santo, Tetsuo

    发明人： SANTO, Tetsuo ,  LI, Songhua ,  WANG, Ruwei ,  IWASAKI, Sumio

    IPC分类号： A61K35/78 ,  A61K31/10 ,  A61K31/16 ,  A61K7/00 ,  A61K7/48 ,  A61P17/00 ,  A61P7/00

    CPC分类号： A61K36/575 ,  A61K31/10 ,  A61K31/16 ,  A61K36/185 ,  A61K36/315 ,  A61K36/48 ,  A61K36/65 ,  A61K36/9066 ,  A61K2300/00

    摘要： TECHNICAL FIELD: Lotion for therapy of dermatitis
    TECHNICAL PROBLEM: To provide a lotion for therapy effective against atopic dermatitis.
    MEANS FOR SOLVING: It has a composition: Lightyellow Sophora Root, 3%; Turmeric, 2%; Magnolia Bark, 2%; Moutan Bark, 2%; Isatis Leaf, 1%; Borneo Camphor Tree (Dryobalanops aromatica Gaertn.f.), 1%; Amur Cork Tree, 2%; Angelicae Dahuricae Root, 1%; Lemon, 3%; Smartweed, 2%; Licorice, 0.5%; Cnidii Rhizoma, 0.5%; Japanese Angelica Root, 0.5%; salicylic acid, 0.5%; resorcinol, 0.5%; alcohol, 30%; and water, 48.5%.
    A significant therapeutic effect against atopic dermatitis is obtained by a synergistic effect between antibacterial, antiviral, antiallergic, antiphlogistic, and blood-circulation accelerating actions as pharmacological effects of Lightyellow Sophora Root, Turmeric, Magnolia Bark, Moutan Bark, Isatis Leaf, Borneo Camphor Tree (Dryobalanops aromatica Gaertn.f.), Amur Cork Tree, Angelicae Dahurikae Root, Lemon, Smartweed, and Licorice, accelerating action for skin permeation and antifungal-sterilizing action of Cnidii Rhizoma and Japanese Angelicae Root, accelerating action for keratinization and antifungal-sterilizing action of salicylic acid and resorcinol, as described above.
    Principal Use: It is used for the therapy of dermatitis, particularly of atopic dermatitis.

    摘要翻译： 技术领域：用于治疗皮炎的乳液技术问题：提供一种治疗有效抵抗特应性皮炎的治疗剂。 解决方法：它有一个组成：Lightyellow Sophora Root，3％; 姜黄，2％; 木兰树皮2％; 木桐树皮2％; Is叶1％; 婆罗洲樟树（Dryobalanops aromatica Gaertn.f。），1％; 阿穆尔软木树，2％; 当归Dahuricae根，1％; 柠檬，3％ Smartweed，2％; 甘草，0.5％; Cnidii Rhizoma，0.5％; 日本当归根，0.5％; 水杨酸，0.5％; 间苯二酚，0.5％; 酒精，30％; 和水，48.5％。 通过抗菌，抗病毒，抗过敏，消炎和血液循环加速作用之间的协同作用，获得了对特应性皮炎的显着治疗作用，作为Lightyellow Sophora Root，姜黄，木兰树皮，Moutan Bark，Isatis Leaf的药理作用 ，婆罗洲樟树（Dryobalanops aromatica Gaertn.f。），阿穆尔软木树，当归Dahurikae根，柠檬，仙妮草和甘草，加速ii for和日本当归的皮肤渗透和抗真菌灭菌作用，加速角化作用 和水杨酸和间苯二酚的抗真菌灭菌作用。 主要用途：用于治疗皮炎，特别是特应性皮炎。